BeLiver
BeLiver offers an AI-powered clinical decision support platform that helps oncologists choose personalized cancer treatments. It combines high-resolution proteomic profiling with machine learning to predict individual patient responses across therapies. The system translates complex biological signals into clinician-ready reports, targeting hepatic cancer initially and expanding to other cancers. BeLiver seeks partnerships with clinicians, researchers, pharma companies, and hospitals to scale adoption and advance precision medicine. This approach also reveals novel protein targets and accelerates discovery.
BeLiver
BeLiver offers an AI-powered clinical decision support platform that helps oncologists choose personalized cancer treatments. It combines high-resolution proteomic profiling with machine learning to predict individual patient responses across therapies. The system translates complex biological signals into clinician-ready reports, targeting hepatic cancer initially and expanding to other cancers. BeLiver seeks partnerships with clinicians, researchers, pharma companies, and hospitals to scale adoption and advance precision medicine. This approach also reveals novel protein targets and accelerates discovery.